- Mersana Therapeutics (NASDAQ:MRSN) appoints Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy.
- David A. Spellman, Chief Financial Officer of the Company will also resign to pursue other opportunities.
- Mr. DeSchuytner joins Mersana from TESARO, where he was Vice President responsible for the ZEJULA (niraparib) commercialization. He will start at Mersana on July 10.
New Finance VP at Mersana Therapeutics
Recommended For You
More Trending News
About MRSN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MRSN | - | - |
Mersana Therapeutics, Inc. |